Pure Global

Technical Development of Cardiovascular Magnetic Resonance Imaging - Trial NCT04927429

Access comprehensive clinical trial information for NCT04927429 through Pure Global AI's free database. This phase not specified trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI) and is currently Recruiting. The study focuses on Cardiovascular Disease. Target enrollment is 3400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04927429
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT04927429
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Technical Development of Cardiovascular Magnetic Resonance Imaging
Technical Development of Cardiovascular MRI

Study Focus

Cardiovascular Disease

Observational

Sponsor & Location

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health Clinical Center (CC)

Bethesda, United States of America

Timeline & Enrollment

N/A

Mar 21, 2022

Dec 31, 2031

3400 participants

Primary Outcome

To evaluate performance of novel pulse sequences for cardiovascular MRI in patients and healthy volunteers of both genders

Summary

Background:
 
 In the U.S., over 6.5 million people have heart failure. Researchers want to develop new
 testing methods for cardiovascular problems using magnetic resonance imaging (MRI) to improve
 the clinical diagnosis and management of people with heart failure.
 
 Objective:
 
 To develop and test new methods for imaging the heart and blood vessels using MRI.
 
 Eligibility:
 
 People ages 18 years and older who are having an MRI of their heart or blood vessels. Healthy
 volunteers are also needed.
 
 Design:
 
 Participants will be screened with a medical history.
 
 Participants will have a physical exam and blood tests. They will have an electrocardiogram
 (ECG) to measure the heart s electrical activity. Then they will have their scheduled MRI
 scan. The MRI scanner is a large, hollow tube. Participants will lie on a table that moves in
 and out of the tube. During the MRI, they may have contrast dye injected through an
 intravenous line inserted into their arm or hand. ECG may be used to monitor their heartbeat
 or coordinate pictures with their heartbeat. A flexible belt may be used to monitor their
 breathing. A finger probe may be used to track their heart rate and/or oxygenation level.
 Their blood pressure may be measured. Pictures may be taken of their blood vessels, heart,
 and lungs before, during, and after they get medicine to increase blood flow. They may lie
 flat and pedal a stress bicycle to increase their heart rate.
 
 Participation will last for 5 years. During that time, participants may receive a yearly
 survey about their health. They may be contacted for an optional follow-up MRI within 2 years
 of their MRI.

ICD-10 Classifications

Cardiovascular disease, unspecified
Hypertensive heart disease
Heart disease, unspecified
Atherosclerotic cardiovascular disease, so described
Atherosclerotic heart disease

Data Source

ClinicalTrials.gov

NCT04927429

Non-Device Trial